Epigenomics may begin to explain in vitro differential response to hypomethylating agents in MMR-D hypermethylated endometrial cancer. Supplementary Tables 1-3.
dataset
posted on 2023-05-22, 08:45 authored by Louis Y. El Khoury, Wan Hsin Lin, James B. Smadbeck, Dorsay Sadeghian, , Alexa F McCune, Giannoula Karagouga, John C Cheville, Michael T Barrett, Faye R Harris, Lindsey M Kinsella, Ryan W Feathers, Janet L Schafer Klein, Marina RS Walther-Antonio, Sarah H Johnson, Alan R. Penheiter, Giuseppe Cucinella, Gabriella Schivardi, Aditya BhagwateAditya Bhagwate, Mitesh J Borad, Aaron S Mansfield, Stephen J Murphy, Andrea Mariani, George Vasmatzis, Panos Z Anastasiadis, Saravut J Weroha, Alyssa M LarishSupplementary Tables 1-3.
